Search research articles
Contact Us
Filters
Showing results (41-50 of 136) with videos related to
Page
of 14
Sort By:
The Journal of Allergy and Clinical Immunology
|
May 20, 2015
Peanut oral immunotherapy transiently expands circulating Ara h 2-specific B cells with a homologous repertoire in unrelated subjects
Sarita U Patil, Adebola O Ogunniyi, Agustin Calatroni, et al.
Clinical Lung Cancer
|
October 27, 2015
Disease Control Rate at 8 Weeks Predicts Subsequent Survival in Platinum-Treated Extensive Stage Small-Cell Lung Cancer: Results From the Southwest Oncology Group (SWOG) Database
Primo N Lara, James Moon, Mary W Redman, et al.
Gynecologic Oncology
|
January 2, 2010
Single agent carboplatin versus carboplatin plus pegylated liposomal doxorubicin in recurrent ovarian cancer: final survival results of a SWOG (S0200) phase 3 randomized trial
Maurie Markman, James Moon, Sharon Wilczynski, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 23, 2015
SWOG S0722: phase II study of mTOR inhibitor everolimus (RAD001) in advanced malignant pleural mesothelioma (MPM)
Sai-Hong Ignatius Ou, James Moon, Linda L Garland, et al.
Oncology Reports
|
April 9, 2013
Predictive factors in patients with advanced and metastatic squamous cell carcinoma of the head and neck: a study based on SWOG protocol S0420
Smita Mehta, James Moon, Mehmood Hashmi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 9, 2014
Randomised phase II study of docetaxel plus vandetanib versus docetaxel followed by vandetanib in patients with persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: SWOG S0904
Robert L Coleman, James Moon, Anil K Sood, et al.
Frontiers in Oncology
|
September 7, 2013
A Pilot Study (SWOG S0429) of Weekly Cetuximab and Chest Radiotherapy for Poor-Risk Stage III Non-Small Cell Lung Cancer
Yuhchyau Chen, James Moon, Kishan J Pandya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 31, 2004
Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial
Susan G Urba, James Moon, P G Shankar Giri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 10, 2012
Randomized phase II trial of sorafenib with temsirolimus or tipifarnib in untreated metastatic melanoma (S0438)
Kim A Margolin, James Moon, Lawrence E Flaherty, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 10, 2014
Relevance of platinum-sensitivity status in relapsed/refractory extensive-stage small-cell lung cancer in the modern era: a patient-level analysis of southwest oncology group trials
Primo N Lara, James Moon, Mary W Redman, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 136) with videos related to
Sort By:
Page
of 14
The Journal of Allergy and Clinical Immunology
|
May 20, 2015
Peanut oral immunotherapy transiently expands circulating Ara h 2-specific B cells with a homologous repertoire in unrelated subjects
Sarita U Patil, Adebola O Ogunniyi, Agustin Calatroni, et al.
Clinical Lung Cancer
|
October 27, 2015
Disease Control Rate at 8 Weeks Predicts Subsequent Survival in Platinum-Treated Extensive Stage Small-Cell Lung Cancer: Results From the Southwest Oncology Group (SWOG) Database
Primo N Lara, James Moon, Mary W Redman, et al.
Gynecologic Oncology
|
January 2, 2010
Single agent carboplatin versus carboplatin plus pegylated liposomal doxorubicin in recurrent ovarian cancer: final survival results of a SWOG (S0200) phase 3 randomized trial
Maurie Markman, James Moon, Sharon Wilczynski, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 23, 2015
SWOG S0722: phase II study of mTOR inhibitor everolimus (RAD001) in advanced malignant pleural mesothelioma (MPM)
Sai-Hong Ignatius Ou, James Moon, Linda L Garland, et al.
Oncology Reports
|
April 9, 2013
Predictive factors in patients with advanced and metastatic squamous cell carcinoma of the head and neck: a study based on SWOG protocol S0420
Smita Mehta, James Moon, Mehmood Hashmi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 9, 2014
Randomised phase II study of docetaxel plus vandetanib versus docetaxel followed by vandetanib in patients with persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: SWOG S0904
Robert L Coleman, James Moon, Anil K Sood, et al.
Frontiers in Oncology
|
September 7, 2013
A Pilot Study (SWOG S0429) of Weekly Cetuximab and Chest Radiotherapy for Poor-Risk Stage III Non-Small Cell Lung Cancer
Yuhchyau Chen, James Moon, Kishan J Pandya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 31, 2004
Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial
Susan G Urba, James Moon, P G Shankar Giri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 10, 2012
Randomized phase II trial of sorafenib with temsirolimus or tipifarnib in untreated metastatic melanoma (S0438)
Kim A Margolin, James Moon, Lawrence E Flaherty, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 10, 2014
Relevance of platinum-sensitivity status in relapsed/refractory extensive-stage small-cell lung cancer in the modern era: a patient-level analysis of southwest oncology group trials
Primo N Lara, James Moon, Mary W Redman, et al.
Page
of 14